Hidradenitis suppurativa: A comprehensive review

Journal of the American Academy of Dermatology

Volumn 60, Issue 4, 2009, Pages 539-561

  Alikhan, Ali ^b   Lynch, Peter J ^a   Eisen, Daniel B ^a  

^a Department of Dermatology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acne inversa; etanercept; hidradenitis suppurativa; infliximab; Verneuil disease

Indexed keywords

ADALIMUMAB; ANTIANDROGEN; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN A; CYPROTERONE ACETATE; DAPSONE; DIANE; ETANERCEPT; ETHINYLESTRADIOL PLUS NORGESTREL; FINASTERIDE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROTOXIN; PLACEBO; PREDNISONE; RETINOID; RIFAMPICIN; TACROLIMUS; TETRACYCLINE;

ACNE CONGLOBATA; ACNE VULGARIS; APOCRINE GLAND; AXILLA; BACTERIAL INFECTION; BREAST; CELLULITIS; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOCRINOLOGY; ENVIRONMENTAL FACTOR; FIBROSIS; FOX FORDYCE DISEASE; HEREDITY; HORMONAL THERAPY; HOST RESISTANCE; HUMAN; HURLEY STAGING SYSTEM; INFLAMMATION; LONG TERM CARE; LOW DRUG DOSE; MORBIDITY; NONHUMAN; OBESITY; PATHOGENESIS; PERINEUM; PHOTOTHERAPY; PHYSIOLOGY; PILONIDAL SINUS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; PUBERTY; RADIOFREQUENCY; RADIOTHERAPY; REVIEW; SCORING SYSTEM; SUPPURATIVE HIDRADENITIS; UNSPECIFIED SIDE EFFECT;

ALGORITHMS; HIDRADENITIS SUPPURATIVA; HUMANS; PROGNOSIS;

EID: 61849173997     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.11.911     Document Type: Review

References (224)

1. Slade D.E., Powell B.W., and Mortimer P.S. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 56 (2003) 451-461
2. Mortimer P.S., and Lunniss P.J. Hidradenitis suppurativa. J R Soc Med 93 (2000) 420-422
3. Anderson Jr. M.J., and Dockerty M.B. Perianal hidradenitis suppurativa: a clinical and pathologic study. Dis Colon Rectum 1 (1958) 23-31
4. Edlich R.F., Silloway K.A., Rodeheaver G.T., and Cooper P.H. Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa. J Emerg Med 4 (1986) 369-378
5. Habif T.P. Clinical dermatology: a color guide to diagnosis and therapy (2004), Mosby, New York
6. Larralde M., Abad M.E., Munoz A.S., and Luna P. Childhood flexural comedones: a new entity. Arch Dermatol 143 (2007) 909-911
7. Brown T.J., Rosen T., and Orengo I.F. Hidradenitis suppurativa. South Med J 91 (1998) 1107-1114
8. Mustafa E.B., Ali S.D., and Kurtz L.H. Hidradenitis suppurativa: review of the literature and management of the axillary lesion. J Natl Med Assoc 72 (1980) 237-243
9. Jansen T., and Plewig G. What's new in acne inversa (alias hidradenitis suppurativa)?. J Eur Acad Dermatol Venereol 14 (2000) 342-343
10. Ramasastry S.S., Conklin W.T., Granick M.S., and Futrell J.W. Surgical management of massive perianal hidradenitis suppurativa. Ann Plast Surg 15 (1985) 218-223
11. Brunsting H.A. Hidradenitis suppurativa; abscess of the apocrine sweat glands. A study of the clinical and pathologic features, with a report of twenty-two cases and a review of the literature. Arch Derm Syphilol 39 (1939) 108-120
12. Ching C.C., and Stahlgren L.H. Clinical review of hidradenitis suppurativa: management of cases with severe perianal involvement. Dis Colon Rectum 8 (1965) 349-352
13. Wiseman M.C. Hidradenitis suppurativa: a review. Dermatol Ther 17 (2004) 50-54
14. Fitzsimmons J.S., and Guilbert P.R. A family study of hidradenitis suppurativa. J Med Genet 22 (1985) 367-373
15. Thornton J.P., and Abcarian H. Surgical treatment of perianal and perineal hidradenitis suppurativa. Dis Colon Rectum 21 (1978) 573-577
16. Mengesha Y.M., Holcombe T.C., and Hansen R.C. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol 16 (1999) 292-296
17. Harrison B.J., Read G.F., and Hughes L.E. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 75 (1988) 972-975
18. Lewis F., Messenger A.G., and Wales J.K. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol 129 (1993) 447-448
19. Revuz J.E., Canoui-Poitrine F., Wolkenstein P., Viallette C., Gabison G., Pouget F., et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59 (2008) 596-601
20. Jemec G.B., Heidenheim M., and Nielsen N.H. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35 (1996) 191-194
21. Lookingbill D.P. Yield from a complete skin examination. Findings in 1157 new dermatology patients. J Am Acad Dermatol 18 (1988) 31-37
22. Jemec G.B. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 119 (1988) 345-350
23. Fitzsimmons J.S., Guilbert P.R., and Fitzsimmons E.M. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 113 (1985) 1-8
24. Williams S.T., Busby R.C., DeMuth R.J., and Nelson H. Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg 26 (1991) 456-462
25. Mortimer P.S., Dawber R.P., Gales M.A., and Moore R.A. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed) 292 (1986) 245-248
26. Culp C.E. Chronic hidradenitis suppurativa of the anal canal. A surgical skin disease. Dis Colon Rectum 26 (1983) 669-676
27. Parks R.W., and Parks T.G. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 79 (1997) 83-89
28. Wiltz O., Schoetz Jr. D.J., Murray J.J., Roberts P.L., Coller J.A., and Veidenheimer M.C. Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum 33 (1990) 731-734
29. Anderson B.B., Cadogan C.A., and Gangadharam D. Hidradenitis suppurativa of the perineum, scrotum, and gluteal area: presentation, complications, and treatment. J Natl Med Assoc 74 (1982) 999-1003
30. Paletta C., and Jurkiewicz M.J. Hidradenitis suppurativa. Clin Plast Surg 14 (1987) 383-390
31. Chaikin D.C., Volz L.R., and Broderick G. An unusual presentation of hidradenitis suppurativa: case report and review of the literature. Urology 44 (1994) 606-608
32. Yu C.C., and Cook M.G. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 122 (1990) 763-769
33. Jackman R.J. Hidradenitis suppurativa: diagnosis and surgical management of perianal manifestations. Proc R Soc Med 52 suppl (1959) 110-112
34. Jackman R.J., and McQuarrie H.B. Hidradenitis suppurativa; its confusion with pilonidal disease and anal fistula. Am J Surg 77 (1949) 349-351
35. Barth J.H., Layton A.M., and Cunliffe W.J. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 134 (1996) 1057-1059
36. Hurley H. Dermatologic surgery, principles and practice (1989), Marcel Dekker, New York
37. Jemec G.B., and Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39 (1998) 971-974
38. Sartorius K., Lapins J., Emtestam L., and Jemec G.B. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149 (2003) 211-213
39. Gordon S.W. Hidradenitis suppurativa: a closer look. J Natl Med Assoc 70 (1978) 339-343
40. Schiefferdecker P. Uber morphologische Sekretionserscheinungen in den ekkrinen Hatadrfisen des Menschen. Arch Derm Syphilol 182 (1921) 130
41. Shelley W.B., and Cahn M.M. The pathogenesis of hidradenitis suppurativa in man; experimental and histologic observations. AMA Arch Derm 72 (1955) 562-565
42. Anderson D.K., and Perry A.W. Axillary hidradenitis. Arch Surg 110 (1975) 69-72
43. Heller D.S., Haefner H.K., Hameed M., and Lieberman R.W. Vulvar hidradenitis suppurativa. Immunohistochemical evaluation of apocrine and eccrine involvement. J Reprod Med 47 (2002) 695-700
44. Morgan W.P., and Hughes L.E. The distribution, size and density of the apocrine glands in hidradenitis suppuritiva. Br J Surg 66 (1979) 853-856
45. Jemec G.B., Thomsen B.M., and Hansen U. The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS 105 (1997) 378-383
46. Attanoos R.L., Appleton M.A., and Douglas-Jones A.G. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133 (1995) 254-258
47. Jemec G.B., and Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol 34 (1996) 994-999
48. Lapins J., Jarstrand C., and Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 140 (1999) 90-95
49. Jemec G.B., and Gniadecka M. Ultrasound examination of hair follicles in hidradenitis suppurativa. Arch Dermatol 133 (1997) 967-970
50. Kurzen H., Kurokawa I., Jemec G.B., Emtestam L., Sellheyer K., Giamarellos-Bourboulis E.J., et al. What causes hidradenitis suppurativa?. Exp Dermatol 17 (2008) 455-456
51. Gniadecki R., and Jemec G.B. Lipid raft-enriched stem cell-like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp Dermatol 13 (2004) 361-363
52. Von Der Werth J.M., Williams H.C., and Raeburn J.A. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 142 (2000) 947-953
53. Gao M., Wang P.G., Cui Y., Yang S., Zhang Y.H., Lin D., et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol 126 (2006) 1302-1306
54. Barth J.H., and Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol 125 (1991) 304-308
55. Stellon A.J., and Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ 298 (1989) 28-29
56. Jemec G.B., Heidenheim M., and Nielsen N.H. Hidradenitis suppurativa-characteristics and consequences. Clin Exp Dermatol 21 (1996) 419-423
57. Cornbleet T. Pregnancy and apocrine gland diseases: hidradenitis, Fox-Fordyce disease. AMA Arch Derm Syphilol 65 (1952) 12-19
58. Harrison B.J., Kumar S., Read G.F., Edwards C.A., Scanlon M.F., and Hughes L.E. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg 72 (1985) 1002-1004
59. Highet A.S., Warren R.E., and Weekes A.J. Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol 124 (1988) 1047-1051
60. Leach R.D., Eykyn S.J., Phillips I., Corrin B., and Taylor E.A. Anaerobic axillary abscess. Br Med J 2 (1979) 5-7
61. Steiner K., and Grayson L.D. Hidradenitis suppurativa of the adult and its management. AMA Arch Derm 71 (1955) 205-211
62. Tennant Jr. F., Bergeron J.R., Stone O.J., and Mullins J.F. Anemia associated with hidradenitis suppurativa. Arch Dermatol 98 (1968) 138-140
63. Shaughnessy D.M., Greminger R.R., Margolis I.B., and Davis W.C. Hidradenitis suppurativa. A plea for early operative treatment. JAMA 222 (1972) 320-321
64. Bendahan J., Paran H., Kolman S., Neufeld D.M., and Freund U. The possible role of Chlamydia trachomatis in perineal suppurative hidradenitis. Eur J Surg 158 (1992) 213-215
65. Jemec G.B., Faber M., Gutschik E., and Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology 193 (1996) 203-206
66. Morgan W.P., and Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol 118 (1982) 101-102
67. Dvorak V.C., Root R.K., and MacGregor R.R. Host-defense mechanisms in hidradenitis suppurativa. Arch Dermatol 113 (1977) 450-453
68. Lapins J., Asman B., Gustafsson A., Bergstrom K., and Emtestam L. Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm Venereol 81 (2001) 96-99
69. Giamarellos-Bourboulis E.J., Antonopoulou A., Petropoulou C., Mouktaroudi M., Spyridaki E., Baziaka F., et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 156 (2007) 51-56
70. Rosi Y.L., Lowe L., and Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatolog Treat 16 (2005) 58-61
71. Lugering A., Schmidt M., Lugering N., Pauels H.G., Domschke W., and Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121 (2001) 1145-1157
72. Drewe E., McDermott E.M., Powell P.T., Isaacs J.D., and Powell R.J. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford) 42 (2003) 235-239
73. Kastner D.L., and O'Shea J.J. A fever gene comes in from the cold. Nat Genet 29 (2001) 241-242
74. Hunger R.E., Surovy A.M., Hassan A.S., Braathen L.R., and Yawalkar N. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 158 (2008) 691-697
75. Kim J., Ochoa M.T., Krutzik S.R., Takeuchi O., Uematsu S., Legaspi A.J., et al. Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169 (2002) 1535-1541
76. Gupta A.K., Knowles S.R., Gupta M.A., Jaunkalns R., and Shear N.H. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 32 (1995) 382-386
77. Aithal V., and Appaih P. Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol 70 (2004) 307-309
78. Marinella M.A. Lithium therapy associated with hidradenitis suppurativa. Acta Derm Venereol 77 (1997) 483
79. Konig A., Lehmann C., Rompel R., and Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 198 (1999) 261-264
80. Rompel R., and Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 26 (2000) 638-643
81. Freiman A., Bird G., Metelitsa A.I., Barankin B., and Lauzon G.J. Cutaneous effects of smoking. J Cutan Med Surg 8 (2004) 415-423
82. Bassukas I.D., and Hundeiker M. Acne inversa (pyodermia fistulans sinifica) and smoking. J Am Acad Dermatol 36 6 pt 1 (1997) 1029
83. Brown S.C., Kazzazi N., and Lord P.H. Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form. Br J Surg 73 (1986) 978-980
84. von der Werth J.M., and Jemec G.B. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 144 (2001) 809-813
85. Wolkenstein P., Loundou A., Barrau K., Auquier P., and Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 56 (2007) 621-623
86. Chicarilli Z.N. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Ann Plast Surg 18 (1987) 230-237
87. Scheinfeld N.S. A case of dissecting cellulitis and a review of the literature. Dermatol Online J 9 (2003) 8
88. Conway H., Stark R.B., Climo S., Weeter J.C., and Garcia F.A. The surgical treatment of chronic hidradenitis suppurativa. Surg Gynecol Obstet 95 (1952) 455-464
89. Hagforsen E., Michaelsson K., Lundgren E., Olofsson H., Petersson A., Lagumdzija A., et al. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study. Acta Derm Venereol 85 (2005) 225-232
90. Gimenez-Garcia R., Sanchez-Ramon S., and Cuellar-Olmedo L.A. Palmoplantar pustulosis: a clinicoepidemiological study. The relationship between tobacco use and thyroid function. J Eur Acad Dermatol Venereol 17 (2003) 276-279
91. Maintz L., Betz R.C., Allam J.P., Wenzel J., Jaksche A., Friedrichs N., et al. Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol 15 (2005) 347-352
92. Montgomery J.R., White T.W., Martin B.L., Turner M.L., and Holland S.M. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. J Am Acad Dermatol 51 (2004) 377-382
93. van Steensel M.A., van Geel M., Nahuys M., Smitt J.H., and Steijlen P.M. A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome. J Invest Dermatol 118 (2002) 724-727
94. Richard G., Rouan F., Willoughby C.E., Brown N., Chung P., Ryynanen M., et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 70 (2002) 1341-1348
95. Bergeron J.R., and Stone O.J. Interstitial keratitis associated with hidradenitis suppurativa. Arch Dermatol 95 (1967) 473-475
96. Balus L., Fazio M., Amantea A., and Menaguale G. Dowling-Degos disease and Verneuil disease. [in French]. Ann Dermatol Venereol 120 (1993) 705-708
97. Bedlow A.J., and Mortimer P.S. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol 21 (1996) 305-306
98. Dixit R., George R., Jacob M., Sudarsanam T.D., and Danda D. Dowling-Degos disease, hidradenitis suppurativa and arthritis in mother and daughter. Clin Exp Dermatol 31 (2006) 454-456
99. Fenske N.A., Groover C.E., Lober C.W., and Espinoza C.G. Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. J Am Acad Dermatol 24 (1991) 888-892
100. Kleeman D., Trueb R.M., and Schmid-Grendelmeier P. Reticular pigmented anomaly of the flexures. Dowling-Degos disease of the intertrigo type in association with acne inversa. [in German]. Hautarzt 52 (2001) 642-645
101. Li M., Hunt M.J., and Commens C.A. Hidradenitis suppurativa, Dowling Degos disease and perianal squamous cell carcinoma. Australas J Dermatol 38 (1997) 209-211
102. Loo W.J., Rytina E., and Todd P.M. Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad. Clin Exp Dermatol 29 (2004) 622-624
103. Weber L.A., Kantor G.R., and Bergfeld W.F. Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma. Cutis 45 (1990) 446-450
104. Bhalla R., and Sequeira W. Arthritis associated with hidradenitis suppurativa. Ann Rheum Dis 53 (1994) 64-66
105. Ellis B.I., Shier C.K., Leisen J.J., Kastan D.J., and McGoey J.W. Acne-associated spondylarthropathy: radiographic features. Radiology 162 (1987) 541-545
106. Leybishkis B., Fasseas P., Ryan K.F., and Roy R. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy. Am J Med Sci 321 (2001) 195-197
107. Libow L.F., and Friar D.A. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis 64 (1999) 87-90
108. Rosner I.A., Burg C.G., Wisnieski J.J., Schacter B.Z., and Richter D.E. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol 20 (1993) 684-687
109. Rosner I.A., Richter D.E., Huettner T.L., Kuffner G.H., Wisnieski J.J., and Burg C.G. Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata. Ann Intern Med 97 (1982) 520-525
110. Shenefelt P.D. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis 57 (1996) 315-319
111. Thein M., Hogarth M.B., and Acland K. Seronegative arthritis associated with the follicular occlusion triad. Clin Exp Dermatol 29 (2004) 550-552
112. Vasey F.B., Fenske N.A., Clement G.B., Bridgeford P.H., Germain B.F., and Espinoza L.R. Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa. Clin Exp Rheumatol 2 (1984) 309-311
113. Schilling F., and Kessler S. SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases. [in German]. Z Rheumatol 59 (2000) 1-28
114. Steinhoff J.P., Cilursu A., Falasca G.F., Guzman L., and Reginato A.J. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol 8 (2002) 13-22
115. Kahn M.F., Bouvier M., Palazzo E., Tebib J.G., and Colson F. Sternoclavicular pustulotic osteitis (SAPHO). 20-year interval between skin and bone lesions. J Rheumatol 18 (1991) 1104-1108
116. Kahn M.F., and Chamot A.M. SAPHO syndrome. Rheum Dis Clin North Am 18 (1992) 225-246
117. Chamot A.M., and Kahn M.F. SAPHO syndrome. [in German]. Z Rheumatol 53 (1994) 234-242
118. Kahn M.F. Current status of the SAPHO syndrome. [in French]. Presse Med 24 (1995) 338-340
119. Lindor N.M., Arsenault T.M., Solomon H., Seidman C.E., and McEvoy M.T. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72 (1997) 611-615
120. Church J.M., Fazio V.W., Lavery I.C., Oakley J.R., and Milsom J.W. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis 8 (1993) 117-119
121. Martinez F., Nos P., Benlloch S., and Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflammatory Bowel Dis 7 (2001) 323-326
122. Burrows N.P., and Jones R.R. Crohn's disease in association with hidradenitis suppurativa. Br J Dermatol 126 (1992) 523
123. Todd P., Garioch J., Rademaker M., Susskind W., Gemell C., and Thomson J. Pachyonychia congenita complicated by hidradenitis suppurativa: a family study. Br J Dermatol 123 (1990) 663-666
124. Leachman S.A., Kaspar R.L., Fleckman P., Florell S.R., Smith F.J., McLean W.H., et al. Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc 10 (2005) 3-17
125. Feinstein A., Friedman J., and Schewach-Millet M. Pachyonychia congenita. J Am Acad Dermatol 19 (1988) 705-711
126. Moroz A., Lee M.H., and Clark J. Reflex sympathetic dystrophy with hidradenitis suppurativa exacerbation: a case report. Arch Phys Med Rehabil 82 (2001) 412-414
127. Spiller R.F., and Knox J.M. Fox-Fordyce disease with hidradenitis suppurativa. J Invest Dermatol 31 (1958) 127-135
128. Maclean G.M., and Coleman D.J. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 89 (2007) 709-712
129. Kurokawa I., Nishimura K., Yamanaka K., Mizutani H., Tsubura A., and Revuz J. Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). J Cutan Pathol 34 (2007) 675-678
130. Maalouf E., Faye O., Poli F., Cosnes A., and Revuz J. Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab. [in French]. Ann Dermatol Venereol 133 5 pt 1 (2006) 473-474
131. Talmant J.C., Bruant-Rodier C., Nunziata A.C., Rodier J.F., and Wilk A. Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review. [in French]. Ann Chir Plast Esthet 51 (2006) 82-86
132. Short K.A., Kalu G., Mortimer P.S., and Higgins E.M. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Clin Exp Dermatol 30 (2005) 481-483
133. Crain V.A., Gulati S., Bhat S., and Milner S.M. Marjolin's ulcer in chronic hidradenitis suppurativa. Am Fam Physician 71 1652 (2005) 1657
134. Rosenzweig L.B., Brett A.S., Lefaivre J.F., and Vandersteenhoven J.J. Hidradenitis suppurativa complicated by squamous cell carcinoma and paraneoplastic neuropathy. Am J Med Sci 329 (2005) 150-152
135. Bocchini S.F., Habr-Gama A., Kiss D.R., Imperiale A.R., and Araujo S.E. Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum 46 (2003) 944-949
136. Altunay I.K., Gokdemir G., Kurt A., and Kayaoglu S. Hidradenitis suppurativa and squamous cell carcinoma. Dermatol Surg 28 (2002) 88-90
137. Manolitsas T., Biankin S., Jaworski R., and Wain G. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Gynecol Oncol 75 (1999) 285-288
138. Lin M.T., Breiner M., and Fredricks S. Marjolin's ulcer occurring in hidradenitis suppurativa. Plast Reconstr Surg 103 (1999) 1541-1543
139. Ritz J.P., Runkel N., Haier J., and Buhr H.J. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis 13 (1998) 164-168
140. Gur E., Neligan P.C., Shafir R., Reznick R., Cohen M., and Shpitzer T. Squamous cell carcinoma in perineal inflammatory disease. Ann Plast Surg 38 (1997) 653-657
141. Malaguarnera M., Pontillo T., Pistone G., and Succi L. Squamous-cell cancer in Verneuil's disease (hidradenitis suppurativa). Lancet 348 (1996) 1449
142. Dufresne Jr. R.G., Ratz J.L., Bergfeld W.F., and Roenigk R.K. Squamous cell carcinoma arising from the follicular occlusion triad. J Am Acad Dermatol 35 (1996) 475-477
143. Shukla V.K., and Hughes L.E. A case of squamous cell carcinoma complicating hidradenitis suppurativa. Eur J Surg Oncol 21 (1995) 106-109
144. Perez-Diaz D., Calvo-Serrano M., Martinez-Hijosa E., Fuenmayor-Valera L., Munoz-Jimenez F., Turegano-Fuentes F., et al. Squamous cell carcinoma complicating perianal hidradenitis suppurativa. Int J Colorectal Dis 10 (1995) 225-228
145. Welsh D.A., and Powers J.S. Elevated parathyroid hormone-related protein and hypercalcemia in a patient with cutaneous squamous cell carcinoma complicating hidradenitis suppurativa. South Med J 86 (1993) 1403-1404
146. Mendonca H., Rebelo C., Fernandes A., Lino A., and Garcia e Silva L. Squamous cell carcinoma arising in hidradenitis suppurativa. J Dermatol Surg Oncol 17 (1991) 830-832
147. Anstey A.V., Wilkinson J.D., and Lord P. Squamous cell carcinoma complicating hidradenitis suppurativa. Br J Dermatol 123 (1990) 527-531
148. Brown M.D., Zachary C.B., Grekin R.C., and Swanson N.A. Genital tumors: their management by micrographic surgery. J Am Acad Dermatol 18 (1988) 115-122
149. Zachary L.S., Robson M.C., and Rachmaninoff N. Squamous cell carcinoma occurring in hidradenitis suppurativa. Ann Plast Surg 18 (1987) 71-73
150. Sparks M.K., Kuhlman D.S., Prieto A., and Callen J.P. Hypercalcemia in association with cutaneous squamous cell carcinoma. Occurrence as a late complication of hidradenitis suppurativa. Arch Dermatol 121 (1985) 243-246
151. Camisa C. Squamous cell carcinoma arising in acne conglobata. Cutis 33 (1984) 185-187 90
152. Gordon S.W. Squamous cell carcinoma arising in hidradenitis suppurativa: case report. Plast Reconstr Surg 60 (1977) 800-802
153. Humphrey L.J., Playforth H., and Leavell Jr. U.W. Squamous cell carcinoma arising in hidradenitis suppurativum. Arch Dermatol 100 (1969) 59-62
154. Donsky H.J. Complications of hidradenitis suppurative. J Dermatol Surg 2 362 (1976) 415
155. Donsky H.J., and Mendelson C.G. Squamous cell carcinoma as a complication of hidradenitis suppurativa. Arch Dermatol 90 (1964) 488-491
156. Cosman B.C., O'Grady T.C., and Pekarske S. Verrucous carcinoma arising in hidradenitis suppurativa. Int J Colorectal Dis 15 (2000) 342-346
157. Lapins J., Ye W., Nyren O., and Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 137 (2001) 730-734
158. Konety B.R., Cooper T., Flood H.D., and Futrell J.W. Scrotal elephantiasis associated with hidradenitis suppurativa. Plast Reconstr Surg 97 (1996) 1243-1245
159. Russ E., and Castillo M. Lumbosacral epidural abscess due to hidradenitis suppurativa. AJR Am J Roentgenol 178 (2002) 770-771
160. Moschella S.L. Hidradenitis suppurativa. Complications resulting in death. JAMA 198 (1966) 201-203
161. Lee R.A., Yoon A., and Kist J. Hidradenitis suppurativa: an update. Adv Dermatol 23 (2007) 289-306
162. Clemmensen O.J. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 22 (1983) 325-328
163. Mendonca C.O., and Griffiths C.E. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 154 (2006) 977-978
164. Kaur M.R., and Lewis H.M. Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatolog Treat 17 (2006) 211-213
165. Boer J., and van Gemert M.J. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 40 (1999) 73-76
166. Mortimer P.S., Dawber R.P., Gales M.A., and Moore R.A. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115 (1986) 263-268
167. Sawers R.S., Randall V.A., and Ebling F.J. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Br J Dermatol 115 (1986) 269-274
168. Joseph M.A., Jayaseelan E., Ganapathi B., and Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 16 (2005) 75-78
169. Kraft J.N., and Searles G.E. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg 11 (2007) 125-131
170. Bolanowski A., Mannon R.B., Holland S.M., Malech H.L., Aschan J., Palmblad J., et al. Successful renal transplantation in patients with chronic granulomatous disease. Am J Transplant 6 (2006) 636-639
171. Buckley D.A., and Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med 88 (1995) 289P-290P
172. Rose R.F., Goodfield M.J., and Clark S.M. Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin Exp Dermatol 31 (2006) 154-155
173. Tsianos E.V., Dalekos G.N., Tzermias C., Merkouropoulos M., and Hatzis J. Hidradenitis suppurativa in Crohn's disease. A further support to this association. J Clin Gastroenterol 20 (1995) 151-153
174. Jemec G.B. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol 27 (2002) 528-529
175. Moschella S.L. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases. Int J Dermatol 46 (2007) 1287-1291
176. Mekkes J.R., and Bos J.D. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol 158 (2008) 370-374
177. Gheorghe C., Cotruta B., Trifu V., Grasu M., and Gheorghe L. QUIZ HQ 40. Perineal abscesses and fistulas-always a mark of Crohn's disease?. J Gastrointestin Liver Dis 16 (2007) 307-308 342
178. Fernandez-Vozmediano J.M., and Armario-Hita J.C. Infliximab for the treatment of hidradenitis suppurativa. Dermatology 215 (2007) 41-44
179. Pedraz J., Dauden E., Perez-Gala S., Goiriz-Valdes R., Fernandez-Penas P., and Garcia-Diez A. Hidradenitis suppurativa. Response to treatment with infliximab. [in Spanish]. Actas Dermosifiliogr 98 (2007) 325-331
180. Usmani N., Clayton T.H., Everett S., and Goodfield M.D. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol 32 (2007) 204-205
181. Fardet L., Dupuy A., Kerob D., Levy A., Allez M., Begon E., et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 56 (2007) 624-628
182. Thielen A.M., Barde C., and Saurat J.H. Long-term infliximab for severe hidradenitis suppurativa. Br J Dermatol 155 (2006) 1105-1107
183. Alexis A.F., and Strober B.E. Off-label dermatologic uses of anti-TNF-a therapies. J Cutan Med Surg 9 (2005) 296-302
184. Cusack C., and Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol 154 (2006) 726-729
185. Trent J.T., and Kerdel F.A. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases. Dermatol Nurs 17 (2005) 97-107
186. Gupta A.K., and Skinner A.R. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 8 (2004) 77-89
187. Adams D.R., Gordon K.B., Devenyi A.G., and Ioffreda M.D. Severe hidradenitis suppurativa treated with infliximab infusion. Arch Dermatol 139 (2003) 1540-1542
188. Sullivan T.P., Welsh E., Kerdel F.A., Burdick A.E., and Kirsner R.S. Infliximab for hidradenitis suppurativa. Br J Dermatol 149 (2003) 1046-1049
189. Lebwohl B., and Sapadin A.N. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 49 (2003) S275-S276
190. Katsanos K.H., Christodoulou D.K., and Tsianos E.V. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol 97 (2002) 2155-2156
191. Brunasso A.M., Delfino C., and Massone C. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?. Br J Dermatol 159 (2008) 761-763
192. Zangrilli A., Esposito M., Mio G., Mazzotta A., and Chimenti S. Long-term efficacy of etanercept in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 22 (2008) 1260-1262
193. Moul D.K., and Korman N.J. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab. Arch Dermatol 142 (2006) 1110-1112
194. Scheinfeld N. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab. J Am Acad Dermatol 55 (2006) 163-164
195. Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., and Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 (2006) 2275-2285
196. Menter A., Gottlieb A., Feldman S.R., Van Voorhees A.S., Leonardi C.L., Gordon K.B., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58 (2008) 826-850
197. Wallis R.S., Broder M.S., Wong J.Y., Hanson M.E., and Beenhouwer D.O. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38 (2004) 1261-1265
198. Slifman N.R., Gershon S.K., Lee J.H., Edwards E.T., and Braun M.M. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 48 (2003) 319-324
199. Lee J.H., Slifman N.R., Gershon S.K., Edwards E.T., Schwieterman W.D., Siegel J.N., et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 46 (2002) 2565-2570
200. Brocard A., Knol A.C., Khammari A., and Dreno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology 214 (2007) 325-327
201. Norris C. Hidradenitis and response to oral steroids. Br J Dermatol 117 suppl 32 (1987) 96-97
202. Treatment of hidradenitis suppurativa. JAMA 223 (1973) 556-557
203. Kipping H.F. How I treat hidradenitis suppurativa. Postgrad Med J 48 (1970) 291-292
204. Camisa C., Sexton C., and Friedman C. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report. J Reprod Med 34 (1989) 543-546
205. Danto J.L. Preliminary studies of the effect of hydrocortisone on hidradenitis suppurativa. J Invest Dermatol 31 (1958) 299-300
206. O'Reilly D.J., Pleat J.M., and Richards A.M. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg 116 (2005) 1575-1576
207. Zeligman I. Temporary x-ray epilation therapy of chronic axillary hidradenitis suppurativa. Arch Dermatol 92 (1965) 690-694
208. Schenck S.G. Hidradenitis suppurativa axillaris; an analysis of 54 cases treated with roentgen rays. Radiology 54 (1950) 74-77
209. Pape R., and Golles D. Effect of roentgen microdosage in axillar hidrosadenitis. [in German]. Strahlentherapie 81 (1950) 565-576
210. Frohlich D., Baaske D., and Glatzel M. Radiotherapy of hidradenitis suppurativa-still valid today?. [in German]. Strahlenther Onkol 176 (2000) 286-289
211. Pedraz J., and Dauden E. Practical management of hidradenitis suppurativa. [in Spanish]. Actas Dermosifiliogr 99 (2008) 101-110
212. Bong J.L., Shalders K., and Saihan E. Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy. Clin Exp Dermatol 28 (2003) 241-244
213. Dalrymple J.C., and Monaghan J.M. Treatment of hidradenitis suppurativa with the carbon dioxide laser. Br J Surg 74 (1987) 420
214. Lapins J., Sartorius K., and Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 47 (2002) 280-285
215. Sherman A.I., and Reid R. CO2 laser for suppurative hidradenitis of the vulva. J Reprod Med 36 (1991) 113-117
216. Wasaki J., Marra D.E., Fincher E.F., and Moy R.L. Treatment of hidradenitis suppurativa with a nonablative radiofrequency device. Dermatol Surg 34 (2008) 114-117
217. Gold M., Bridges T.M., Bradshaw V.L., and Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3 (2004) S32-S35
218. Rivard J., and Ozog D. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol 5 (2006) 556-561
219. Strauss R.M., Pollock B., Stables G.I., Goulden V., and Cunliffe W.J. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 152 (2005) 803-804
220. Harrison B.J., Mudge M., and Hughes L.E. Recurrence after surgical treatment of hidradenitis suppurativa. Br Med J (Clin Res Ed) 294 (1987) 487-489
221. Watson J.D. Hidradenitis suppurativa-a clinical review. Br J Plast Surg 38 (1985) 567-569
222. Mandal A., and Watson J. Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases. Surgeon 3 (2005) 23-26
223. Morgan W.P., Harding K.G., and Hughes L.E. A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa. Ann R Coll Surg Engl 65 (1983) 235-236
224. Jemec G.B.E., Revuz J., and Leyden J.J. Hidradenitis suppurativa (2006), Springer-Verlag, Berlin-Heidelberg-New York